Keratoconus is a disease of the eye that causes gradual weakening and thinning of the cornea. As a result, this can cause visual disturbances such as glare, halos and overall poor vision. It is a progressive disease that tends to get worse over time.
The only current treatment to prevent the progression of Keratoconus is Corneal Collagen Cross Linking. While this treatment has been successfully used internationally for over 10 years, it is still undergoing FDA approval in the U.S. The treatment entails using Riboflavin (a naturally occurring vitamin) in the form of eye drops. These eye drops saturate through the layers of the cornea and are activated by UV light. This causes a chemical reaction that strengthens the bonds of the cornea, and halts the progression of Keratoconus.
Our office is a part of a 16 site, multicenter clinical trial performing epithelial-on cross linking. We have been enrolled in the study since 2011 and we have performed over 200 procedures thus far.
Request an appointment to find out if you are a candidate for Cross Linking.